Biosimilars in Cancer

1 Edición - 1 de diciembre de 2026
Última edición
Editores: Ranjita Shegokar, Yashwant Pathak
Idioma: Inglés

Biosimilars in Cancer is a comprehensive resource addressing the role of biosimilars in treating various cancer types. This book offers a succinct yet thorough overview of curren… Leer más

Descripción

Biosimilars in Cancer is a comprehensive resource addressing the role of biosimilars in treating various cancer types. This book offers a succinct yet thorough overview of current trends in oncology, covering 21 different cancers from liver to breast cancer. Each chapter provides detailed insights into the latest trends, fundamental facts, and practical and clinical data, making it an invaluable tool for academics and practitioners. By compiling this rich content into a single, accessible volume, the book empowers researchers and clinicians to enhance their understanding, and improve patient outcomes through the effective use of biosimilars in oncology. Targeted primarily at pharmaceutical researchers, biomedical scientists, and clinicians, Biosimilars in Cancer supports the growing oncology biosimilars market. It also provides critical insights for those involved in cancer diagnostics and clinical trials, helping them stay ahead in this rapidly progressing field.

Puntos claves

Offers detailed information on 21 different cancer types, ensuring a broad understanding of biosimilar applications in oncology
Presents up-to-date insights into the rapidly evolving field of cancer treatment, helping researchers and clinicians stay ahead
Integrates fundamental facts with practical and clinically relevant data, making it a valuable resource for academic and clinical purposes

De interès para

Pharmaceutical researchers, biomedical scientists, and clinicians who are involved in cancer treatment and research

Índice

1. Liver Cancer: Biosimilars in Cancer Research

2. Pancreatic Cancer: Biosimilars in Cancer Research

3. Heart Cancer: Biosimilars in Cancer Research

4. Bone Cancer: Biosimilars in Cancer Research

5. Spleen Cancer: Biosimilars in Cancer Research

6. ENT Cancer: Biosimilars in Cancer Research

7. Brain/CNS Cancer: Biosimilars in Cancer Research

8. Skin Cancer: Biosimilars in Cancer Research

9. Lung Cancer: Biosimilars in Cancer Research

10. Thorax Cancer: Biosimilars in Cancer Research

11. Thyroid Cancer: Biosimilars in Cancer Research

12. Kidney-Adrenal Cancer: Biosimilars in Cancer Research

13. Urinary Tract Cancer: Biosimilars in Cancer Research

14. Breast Cancer: Biosimilars in Cancer Research

15. Colorectal Cancer: Biosimilars in Cancer Research

16. Blood Cancer: Biosimilars in Cancer Research

17. Prostate Cancer: Biosimilars in Cancer Research

18. Ovarian Cancer: Biosimilars in Cancer Research

19. Stomach and Intestinal Cancer: Biosimilars in Cancer Research

20. Pleura and Peritoneum Cancer: Biosimilars in Cancer Research

21. Oral Cancer: Biosimilars in Cancer Research

Detalles del producto

Edición: 1
Última edición
Publicado: 1 de diciembre de 2026
Idioma: Inglés

Sobre los editores

Ranjita Shegokar

Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)

Afiliaciones y experiencia

Postdoctoral Researcher, Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics, Free University of Berlin, Germany

Yashwant Pathak

Yashwant Pathak is a Professor at Taneja College of Pharmacy at the University of South Florida, FL, United States. His area of research is nanotechnology, drug delivery systems, and nutraceuticals. He is also an Ad junct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.